Author： Hemmings S.M.J. Kinnear C.J. Niehaus D.J.H. Moolman-Smook J.C. Lochner C. Knowles J.A. Corfield V.A. Stein D.J.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.13, Iss.2, 2003-03, pp. : 93-98
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Frisch A. Michaelovsky E. Rockah R. Amir I. Hermesh H. Laor N. Fuchs C. Zohar J. Lerer B. Buniak S.F. Landa S. Poyurovsky M. Shapira B. Weizman R.
European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. :
Access to resources
Recommend
Advances in the pharmacotherapy of obsessive-compulsive disorder
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Pathogenetic mechanism of obsessive-compulsive disorder
By Kafka J. Paacute lovaacute E.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Animal Models for Obsessive-Compulsive Disorder
Current Neuropharmacology, Vol. 2, Iss. 2, 2004-04 ,pp. :
Treating obsessive-compulsive disorder with serotonin reuptake inhibitors
By Koran L.M.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :